Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$146 Mln
Revenue (TTM)
$44 Mln
Net Profit (TTM)
$-19 Mln
ROE
-0.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
6.4
Industry P/E
39.28
EV/EBITDA
-11.8
Div. Yield
0 %
Debt to Equity
0.3
Book Value
$--
EPS
$-0.1
Face value
--
Shares outstanding
182,378,000
CFO
$-240.35 Mln
EBITDA
$-237.36 Mln
Net Profit
$-306.59 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Marrone Bio Innovations (MBII)
| 11.1 | -22.3 | -27.9 | -36.5 | -14.5 | -7.3 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Marrone Bio Innovations (MBII)
| -42.4 | 23.8 | -31.3 | 33.4 | -48.6 | 94.5 | -69.5 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for... increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina. Read more
CEO & Director
Mr. Kevin R. Helash
CEO & Director
Mr. Kevin R. Helash
Headquarters
Raleigh, NC
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Marrone Bio Innovations Inc (MBII) is $0.80 (NASDAQ) as of 03-Aug-2022 09:30 EDT. Marrone Bio Innovations Inc (MBII) has given a return of -14.5% in the last 3 years.
Since, TTM earnings of Marrone Bio Innovations Inc (MBII) is negative, P/E ratio is not available.
The P/B ratio of Marrone Bio Innovations Inc (MBII) is 6.36 times as on 03-Aug-2022, a 196 premium to its peers’ median range of 2.15 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
-7.61
|
4.25
|
|
2020
|
-3,514.15
|
5.93
|
|
2019
|
-3.21
|
5.06
|
|
2018
|
-7.35
|
11.48
|
|
2017
|
-1.03
|
-0.63
|
The 52-week high and low of Marrone Bio Innovations Inc (MBII) are Rs -- and Rs -- as of 04-Apr-2026.
Marrone Bio Innovations Inc (MBII) has a market capitalisation of $ 146 Mln as on 03-Aug-2022. As per SEBI classification, it is a Small Cap company.
Before investing in Marrone Bio Innovations Inc (MBII), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.